Nasdaq News

Key PointsPayPal trades at a steep discount to the market, reflecting real concerns about checkout competition and slowing growth.

(RTTNews) - MediciNova, Inc. (MNOV) announced topline results from the Phase 2 MN-001-NATG-202 study evaluating MN-001 in patients with hypertriglyceridemia and non-alcoholic fatty liver disease associated with type 2 diabetes mellitus (T2DM).

In recent trading, shares of City Holding Co. (Symbol: CHCO) have crossed above the average analyst 12-month target price of $140.40, changing hands for $141.97/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v

In recent trading, shares of Perrigo Company plc (Symbol: PRGO) have crossed above the average analyst 12-month target price of $15.25, changing hands for $15.42/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself.

In recent trading, shares of Expeditors International of Washington, Inc. (Symbol: EXPD) have crossed above the average analyst 12-month target price of $183.93, changing hands for $187.46/share. When a stock reaches the target an analyst has set, the analyst logically has two w

(RTTNews) - France's equity benchmark CAC 40 was slightly above the flat line a little past noon on Monday as investors made cautious moves amid concerns about inflation and growth due to rising oil prices amid renewed U.S. - Iran tensions.

(RTTNews) - Innovent Biologics, Inc. (IVBXF) announced that China's National Medical Products Administration (NMPA) has approved Jaypirca (pirtobrutinib) as a monotherapy for adults with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) across all lines of therapy

(RTTNews) - Zymeworks (ZYME) said the company now expects total revenue for 2026 to be between $278 million and $292 million and 2026 adjusted EBITDA to be between $114 million and $128 million, excluding the impact of any future transactions. The company announced the updated fi

Key PointsBitcoin needs to become quantum secure within the next five years.

(RTTNews) - Indian shares slumped on Monday as rising oil prices added to inflation and interest-rate concerns.

Key PointsRealty Income is a solid real estate investment trust that yields 5.9% right now.

In recent trading, shares of Neogen Corp (Symbol: NEOG) have crossed above the average analyst 12-month target price of $13.75, changing hands for $13.76/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuatio

In recent trading, shares of BBB Foods Inc (Symbol: TBBB) have crossed above the average analyst 12-month target price of $53.10, changing hands for $53.56/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuat

Key PointsInvesting in an S&P 500 index fund is one of the surest ways to build wealth in the stock market over the long term.

Key PointsNvidia's growth and profit margin are unparalleled.

(RTTNews) - Gold prices fell sharply on Monday as surging oil prices and elevated bond yields added to worries that the U.S. Federal Reserve will continue raising interest rates next month.

(RTTNews) - Battery maker Amprius Technologies, Inc. (AMPX), announced on Monday that it has secured a grant of up to $75 million from the U.S. Department of War to convert a domestic electric-vehicle battery line into production of high-energy density cells for unmanned aerial s

Key PointsWall Street analysts are overwhelmingly bullish about Alnylam.

Key PointsSalesforce is integrating AI agents into its software and has shifted away from a paid-set model to a usage-based one.